Medical Device Industry News

Startup Aortica raises $7m in Series A round, names Douthitt CEO

November 21, 2014 by Brad Perriello

Aortica raises $7 million in a Series A funding round for its customized abdominal aortic aneurysm device and names medtech veteran Tom Douthitt as its new CEO.

Aortica raises $7m in Series A round, names new CEO

Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.

Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.

BD-CareFusion deal passes US anti-trust waiting period

November 21, 2014 by Mark Hollmer

Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.

BD-CareFusion deal passes US anti-trust waiting period

Medtronic realigns diabetes unit

November 21, 2014 by Brad Perriello

Medtronic reshapes its diabetes business into 3 divisions 'focused on transforming diabetes care,' CEO Omar Ishrak said this week.

Medtronic realigns diabetes unit

Medtronic (NYSE:MDT) said this week that it realigned its diabetes business to focus on "transforming diabetes care," according to CEO Omar Ishrak.

Baxter IV container recall is Class I

November 21, 2014 by Mark Hollmer

The FDA slaps a Class I recall label on Baxter International's pullback of tainted containers used to prepare intravenous medicines.

Baxter IV container recall is Class I

Baxter's (NYSE:BAX) recall of tainted containers used to prepare intravenous medicines is drawing heightened FDA scrutiny. The regulatory agency slapped a Class I label on the effort, its most serious designation.

Philips Respironics Esprit ventilator recall is Class I

November 21, 2014 by Val Kennedy

The FDA slaps a Class I label on Philips Respironics' recall of its Esprit V1000 and V200 ventilators, over concerns that machines may fail to operate on AC power.

Philips Respironics Esprit ventilator recall is Class I

Justice Dept. recoups $6B in False Claims Act cases

November 21, 2014 by Brad Perriello

The U.S. Justice Dept. says it recouped nearly $6 billion from civil cases alleging fraud and false claims against the federal government, including $2.3 billion from healthcare cases.

Justice Dept. recoups $6B in False Claims Act cases

The U.S. Justice Dept. said it recouped a record $5.69 billion in settlements and judgments from False Claims Act cases during the fiscal year ended Sept. 30, including some $2.3 billion in recoveries from healthcare cases.

J&J demands $7.2 billion from Boston Scientific as trial begins

November 20, 2014 by MassDevice

Johnson & Johnson wants a federal judge to make Boston Scientific cough up some $7.2 billion - 40% of Boston's market cap - over J&J's jilting by Guidant Corp.

J&J demands $7.2 billion from Boston Scientific as trial begins
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp